153 related articles for article (PubMed ID: 9174621)
21. Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.
Xue CB; He X; Corbett RL; Roderick J; Wasserman ZR; Liu RQ; Jaffee BD; Covington MB; Qian M; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
J Med Chem; 2001 Oct; 44(21):3351-4. PubMed ID: 11585440
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the tumour necrosis factor alpha-converting enzyme, TACE/ADAM17.
Cerretti DP
Biochem Soc Trans; 1999 Feb; 27(2):219-23. PubMed ID: 10093737
[No Abstract] [Full Text] [Related]
23. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
Moss ML; Jin SL; Milla ME; Bickett DM; Burkhart W; Carter HL; Chen WJ; Clay WC; Didsbury JR; Hassler D; Hoffman CR; Kost TA; Lambert MH; Leesnitzer MA; McCauley P; McGeehan G; Mitchell J; Moyer M; Pahel G; Rocque W; Overton LK; Schoenen F; Seaton T; Su JL; Becherer JD
Nature; 1997 Feb; 385(6618):733-6. PubMed ID: 9034191
[TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing.
Yamamoto M; Hirayama R; Naruse K; Yoshino K; Shimada A; Inoue S; Kayagaki N; Yagita H; Okumura K; Ikeda S
Drug Des Discov; 1999 Aug; 16(2):119-30. PubMed ID: 10533808
[TBL] [Abstract][Full Text] [Related]
25. Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme.
Kottirsch G; Koch G; Feifel R; Neumann U
J Med Chem; 2002 May; 45(11):2289-93. PubMed ID: 12014967
[TBL] [Abstract][Full Text] [Related]
26. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase.
Lunn CA; Fan X; Dalie B; Miller K; Zavodny PJ; Narula SK; Lundell D
FEBS Lett; 1997 Jan; 400(3):333-5. PubMed ID: 9009225
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
[TBL] [Abstract][Full Text] [Related]
28. (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase.
Beck G; Bottomley G; Bradshaw D; Brewster M; Broadhurst M; Devos R; Hill C; Johnson W; Kim HJ; Kirtland S; Kneer J; Lad N; Mackenzie R; Martin R; Nixon J; Price G; Rodwell A; Rose F; Tang JP; Walter DS; Wilson K; Worth E
J Pharmacol Exp Ther; 2002 Jul; 302(1):390-6. PubMed ID: 12065742
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors.
Venkatesan AM; Davis JM; Grosu GT; Baker J; Zask A; Levin JI; Ellingboe J; Skotnicki JS; Dijoseph JF; Sung A; Jin G; Xu W; McCarthy DJ; Barone D
J Med Chem; 2004 Dec; 47(25):6255-69. PubMed ID: 15566296
[TBL] [Abstract][Full Text] [Related]
30. Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.
Duan JJ; Lu Z; Wasserman ZR; Liu RQ; Covington MB; Decicco CP
Bioorg Med Chem Lett; 2005 Jun; 15(12):2970-3. PubMed ID: 15908214
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha converting enzyme.
Black RA
Int J Biochem Cell Biol; 2002 Jan; 34(1):1-5. PubMed ID: 11733179
[TBL] [Abstract][Full Text] [Related]
32. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
[TBL] [Abstract][Full Text] [Related]
33. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
Black RA; Rauch CT; Kozlosky CJ; Peschon JJ; Slack JL; Wolfson MF; Castner BJ; Stocking KL; Reddy P; Srinivasan S; Nelson N; Boiani N; Schooley KA; Gerhart M; Davis R; Fitzner JN; Johnson RS; Paxton RJ; March CJ; Cerretti DP
Nature; 1997 Feb; 385(6618):729-33. PubMed ID: 9034190
[TBL] [Abstract][Full Text] [Related]
34. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes.
Borland G; Murphy G; Ager A
J Biol Chem; 1999 Jan; 274(5):2810-5. PubMed ID: 9915814
[TBL] [Abstract][Full Text] [Related]
35. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
[TBL] [Abstract][Full Text] [Related]
36. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.
Hansen HP; Dietrich S; Kisseleva T; Mokros T; Mentlein R; Lange HH; Murphy G; Lemke H
J Immunol; 2000 Dec; 165(12):6703-9. PubMed ID: 11120787
[TBL] [Abstract][Full Text] [Related]
37. The importance of shedding of membrane proteins for cytokine biology.
Müllberg J; Althoff K; Jostock T; Rose-John S
Eur Cytokine Netw; 2000 Mar; 11(1):27-38. PubMed ID: 10705296
[TBL] [Abstract][Full Text] [Related]
38. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells.
Bzowska M; Jura N; Lassak A; Black RA; Bereta J
Eur J Biochem; 2004 Jul; 271(13):2808-20. PubMed ID: 15206946
[TBL] [Abstract][Full Text] [Related]
39. The secretases that cleave angiotensin converting enzyme and the amyloid precursor protein are distinct from tumour necrosis factor-alpha convertase.
Parvathy S; Karran EH; Turner AJ; Hooper NM
FEBS Lett; 1998 Jul; 431(1):63-5. PubMed ID: 9684866
[TBL] [Abstract][Full Text] [Related]
40. Chromen-based TNF-alpha converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation.
Chun K; Park SK; Kim HM; Choi Y; Kim MH; Park CH; Joe BY; Chun TG; Choi HM; Lee HY; Hong SH; Kim MS; Nam KY; Han G
Bioorg Med Chem; 2008 Jan; 16(1):530-5. PubMed ID: 17936631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
